MB-314

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameMB-314
Drug Alias NameMB-314
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3
Targets3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMeridian Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesMeridian Biopharmaceuticals
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A